SCHOTT PHARMA AG& CO KGAA (1SXP.DE) Stock Earnings & Estimates
Europe - Frankfurt Stock Exchange - FRA:1SXP - DE000A3ENQ51 - Common Stock
18.9 EUR
-0.1 (-0.53%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 821.1M 26.58% | 898.602M 9.44% | 957.091M 6.51% | 1.01B 5.53% | 1.099B 8.81% | 1.21B 10.10% | 1.346B 11.24% | 1.46B 8.47% | 2.014B 37.95% | 2.074B 2.98% | |
| EBITDA YoY % growth | 223.5M 47.72% | 217.822M -2.54% | 256.006M 17.53% | 281.07M 9.79% | 320.39M 13.99% | 366.05M 14.25% | 405.12M 10.67% | 452.34M 11.66% | 562.43M 24.34% | 604.82M 7.54% | |
| EBIT YoY % growth | 168.1M 46.30% | 171.174M 1.83% | 191.006M 11.59% | 205.65M 7.67% | 237.48M 15.48% | 272.95M 14.94% | 300.62M 10.14% | 329.76M 9.69% | 358.53M 8.72% | N/A | |
| Operating Margin | 20.47% | 19.05% | 19.96% | 20.36% | 21.61% | 22.56% | 22.33% | 22.59% | 17.80% | N/A | |
| EPS YoY % growth | N/A | N/A | 0.99 4.50% | 1.02 3.25% | 1.17 14.46% | 1.34 14.16% | 1.51 12.88% | 1.68 11.33% | 1.86 10.86% | N/A |
All data in EUR
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.24 8.49% | 0.26 37.16% | 0.29 12.59% | 0.31 4.55% | 0.29 22.65% |
| Revenue Q2Q % growth | 253.29M 6.85% | 250.7M 9.08% | 270.84M 7.34% | 285.49M 11.32% | 272.94M 7.76% |
| EBITDA Q2Q % growth | 62.558M -42.76% | 70.436M 29.16% | 76.553M -12.64% | 81.196M -30.53% | 75.449M 20.61% |
| EBIT Q2Q % growth | 44.197M -0.20% | 49.737M 39.96% | 55.272M 11.36% | 59.105M -1.29% | 54.463M 23.23% |
All data in EUR
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.30 -3.23% | 0.30 | 0.00 | -1.05% |
| Q2 2025 Q2Q % growth | 0.26 52.94% | 0.25 | 0.01 | 5.48% |
| Q1 2025 Q2Q % growth | 0.19 -34.48% | 0.22 | -0.03 | -14.42% |
| Q4 2024 Q2Q % growth | 0.22 -4.35% | 0.25 | -0.03 | -10.99% |
| Q3 2024 Q2Q % growth | 0.31 | 0.21 | 0.10 | 50.83% |
| Q2 2024 Q2Q % growth | 0.17 | 0.21 | -0.04 | -20.63% |
| Q1 2024 Q2Q % growth | 0.29 | 0.28 | 0.01 | 3.11% |
| Q4 2023 Q2Q % growth | 0.23 | 0.16 | 0.07 | 40.93% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 256.46M 1.13% | 262.43M | -5.97M | -2.27% |
| Q2 2025 Q2Q % growth | 252.326M 7.95% | 247.99M | 4.336M | 1.75% |
| Q1 2025 Q2Q % growth | 229.841M -1.04% | 242.74M | -12.899M | -5.31% |
| Q4 2024 Q2Q % growth | 237.051M 3.73% | 244.39M | -7.339M | -3.00% |
| Q3 2024 Q2Q % growth | 253.587M -62.16% | 228.25M | 25.337M | 11.10% |
| Q2 2024 Q2Q % growth | 233.749M | 238.89M | -5.141M | -2.15% |
| Q1 2024 Q2Q % growth | 232.251M | 212M | 20.251M | 9.55% |
| Q4 2023 Q2Q % growth | 228.516M 12.57% | 233.12M | -4.604M | -1.97% |
| Q3 2023 Q2Q % growth | 670.086M 8.41% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | -1.65% | -1.33% |
| Revenue | 0% | 0.61% | -0.3% | -1.08% |